![John Pinion](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 5 M $ in data 30/06/2026
John Richard Pinion currently works at Aroa Biosurgery Ltd., as Independent Non-Executive Director from 2015, Aroa Biosurgery, Inc., as Director, and Ultragenyx Pharmaceutical, Inc., as Chief Quality Operations Officer & Executive VP from 2017.
Mr. Pinion also formerly worked at Baxter BioScience Corp., as Vice President-Quality, Genentech, Inc., as Senior VP, Global Head-Quality & Compliance from 2008 to 2009, and Roche Holding AG, as Senior VP, Global Head-Quality & Compliance from 2009 to 2015.
Mr. Pinion received his undergraduate degree in 1988 from West Virginia University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 16/04/2026 | 133.142 ( 0,14% ) | 4 M $ | 30/06/2026 | |
AROA BIOSURGERY LTD 0,14% | 31/10/2025 | 472.500 ( 0,14% ) | 194 774 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| AROA BIOSURGERY LIMITED | Direttore/Membro del Consiglio | 01/02/2015 |
| ULTRAGENYX PHARMACEUTICAL INC. | Corporate Officer/Principal | 01/07/2015 |
| Società | Posizione | Fine |
|---|---|---|
| ROCHE HOLDING AG | Responsabile della Conformità | 01/07/2015 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Responsabile della Conformità | 01/01/2009 |
Baxter BioScience Corp.
 Baxter BioScience Corp. BiotechnologyHealth Technology Provides biopharmaceutical and vaccines services | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Ultragenyx Pharmaceutical, Inc.
 Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
West Virginia University
 West Virginia University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baxter BioScience Corp.
Baxter BioScience Corp. BiotechnologyHealth Technology Provides biopharmaceutical and vaccines services | Health Technology |
Aroa Biosurgery Ltd.
 Aroa Biosurgery Ltd. Medical SpecialtiesHealth Technology Develops medical devices for soft tissue regeneration and cellular scaffolding | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
